Will FDA approve any mRNA vaccine against prostate adenocarcinoma before 2028?
Health & MedicineOne-Off1aManifold MarketsSem KYCDados de resolução verificadosRazoavelmente calibradoPrevisão da comunidade atualNão 79.4%
Previsores
3
Tipo de pergunta
binary
Metodologia
Play-money forecasting platform
Tipo de fonte
Previsão
Dados do mercado
Atualizado há 23 minutos
21/02/23, 20:25 UTC31/12/27, 22:59 UTC
Tendências
Regras
Resolves YES if the FDA grants full approval for the commercial sale of any mRNA-based vaccine for the treatment of prostate adenocarcinoma in the United States before January 1, 2028.
- This does not include emergency use authorization or other forms of limited authorization.
- Resolves NO otherwise.
Mercados abertos
Health & Medicine
POLYMARKETHantavirus pandemic in 2026?
- No-0.1pt97%
- Yes+0.1pt3%
- Volume total
- € 15,6 mi
- Volume 24h
- € 18,3 mil
KALSHIWill WHO declare Hantavirus a Public Health Emergency of International Concern this Year?
- No96%
- Yes+1.9pt4%
- Volume total
- € 1,6 mi
- Volume 24h
- € 5,2 mil
KALSHIWhen will Intellia Therapeutics submit a BLA for Lonvo-z?
- before October+64.0pt98%
- before 2027+22.0pt98%
- before December+30.0pt98%
+3 mais resultados
POLYMARKETFDA approves skin cancer vaccine by which date?
- December 31,+6.0pt65%
- September+2.0pt41%
- June28%
- Volume total
POLYMARKETNew pandemic in 2026?
- No+0.5pt94%
- Yes-0.5pt6%
- Volume total
- € 916 mil
- Volume 24h
- € 1,5 mil
KALSHIMeasles cases in 2026?
- Above 300099%
- Above 400097%
- Above 6000-2.0pt57%
+2 mais resultados
- Volume total
- € 863,6 mil
- Volume 24h
- € 1 mil
- Ebola pandemic in 2026?
- Will 3 mg THC beverages be federally legal to sell?
- Ebola pandemic in 2026?
- Measles cases in U.S. in 2026?
- FDA decision: Bepirovirsen by GlaxoSmithKline (in 2026)
- When will Heidi Overton be confirmed as Commissioner of the FDA?
- What will the average number of measles cases be during Trump's term?
- Will the FDA approve any psychedelic substance for medical use this year?
- When will the FDA reclassify BPC-157 to Category 1?
- FDA decision: Saroglitazar by Zydus Therapeutics (in 2026)
- Will the FDA approve CagriSema?
Perguntas frequentes
- Quais são as probabilidades atuais de Will FDA approve any mRNA vaccine against prostate adenocarcinoma before 2028??
- A Manifold Markets cota No em 79% em 8 de setembro de 2026.
- Quando Will FDA approve any mRNA vaccine against prostate adenocarcinoma before 2028? é resolvido?
- Will FDA approve any mRNA vaccine against prostate adenocarcinoma before 2028? deverá ser resolvido em 31 de dezembro de 2027.
- Como Will FDA approve any mRNA vaccine against prostate adenocarcinoma before 2028? é liquidado?
- A Manifold Markets liquida este mercado da seguinte forma: Resolves YES if the FDA grants full approval for the commercial sale of any mRNA-based vaccine for the treatment of prostate adenocarcinoma in the United States before January 1, 2028.